These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. ACVR1 mutations in DIPG: lessons learned from FOP. Taylor KR; Vinci M; Bullock AN; Jones C Cancer Res; 2014 Sep; 74(17):4565-70. PubMed ID: 25136070 [TBL] [Abstract][Full Text] [Related]
8. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Wu G; Diaz AK; Paugh BS; Rankin SL; Ju B; Li Y; Zhu X; Qu C; Chen X; Zhang J; Easton J; Edmonson M; Ma X; Lu C; Nagahawatte P; Hedlund E; Rusch M; Pounds S; Lin T; Onar-Thomas A; Huether R; Kriwacki R; Parker M; Gupta P; Becksfort J; Wei L; Mulder HL; Boggs K; Vadodaria B; Yergeau D; Russell JC; Ochoa K; Fulton RS; Fulton LL; Jones C; Boop FA; Broniscer A; Wetmore C; Gajjar A; Ding L; Mardis ER; Wilson RK; Taylor MR; Downing JR; Ellison DW; Zhang J; Baker SJ Nat Genet; 2014 May; 46(5):444-450. PubMed ID: 24705251 [TBL] [Abstract][Full Text] [Related]
9. Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases. Han HJ; Jain P; Resnick AC Bone; 2018 Apr; 109():91-100. PubMed ID: 28780023 [TBL] [Abstract][Full Text] [Related]
10. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma. Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545 [TBL] [Abstract][Full Text] [Related]
11. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nikbakht H; Panditharatna E; Mikael LG; Li R; Gayden T; Osmond M; Ho CY; Kambhampati M; Hwang EI; Faury D; Siu A; Papillon-Cavanagh S; Bechet D; Ligon KL; Ellezam B; Ingram WJ; Stinson C; Moore AS; Warren KE; Karamchandani J; Packer RJ; Jabado N; Majewski J; Nazarian J Nat Commun; 2016 Apr; 7():11185. PubMed ID: 27048880 [TBL] [Abstract][Full Text] [Related]
12. Shared mutation for two childhood diseases. Delude CM J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006195 [No Abstract] [Full Text] [Related]
14. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas. Fortin J; Tian R; Zarrabi I; Hill G; Williams E; Sanchez-Duffhues G; Thorikay M; Ramachandran P; Siddaway R; Wong JF; Wu A; Apuzzo LN; Haight J; You-Ten A; Snow BE; Wakeham A; Goldhamer DJ; Schramek D; Bullock AN; Dijke PT; Hawkins C; Mak TW Cancer Cell; 2020 Mar; 37(3):308-323.e12. PubMed ID: 32142668 [TBL] [Abstract][Full Text] [Related]
15. Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders. Pacifici M; Shore EM Cytokine Growth Factor Rev; 2016 Feb; 27():93-104. PubMed ID: 26776312 [TBL] [Abstract][Full Text] [Related]
16. Recent perspectives of molecular aberrations in pediatric high-grade glioma. Li Z; Sun Q; Shi Y Minerva Pediatr; 2020 Apr; 72(2):116-122. PubMed ID: 28643992 [TBL] [Abstract][Full Text] [Related]
17. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders. Machiya A; Tsukamoto S; Ohte S; Kuratani M; Fujimoto M; Kumagai K; Osawa K; Suda N; Bullock AN; Katagiri T Bone; 2018 Jun; 111():101-108. PubMed ID: 29551750 [TBL] [Abstract][Full Text] [Related]
18. Signal Transduction in Diffuse Intrinsic Pontine Glioma. Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874 [TBL] [Abstract][Full Text] [Related]